More articles from Reviewers

  • TOC Icon

    Shedding: An updated guide to a common cause of hair loss

    Wilma F. Bergfeld, MD and Daniela Mendez, MD
    • Cleveland Clinic Journal of Medicine October 2026, 93 (10) 616-622;
    • DOI: https://doi.org/10.3949/ccjm.93a.26008
    • Telogen effluvium, or hair shedding, results from a temporary disruption of the normal hair growth cycle and typically is reversible.

  • Actinic keratosis: A clinician’s guide to diagnosis and treatment

    CME Image
    Taylor A. Bullock, MD, Michael Christopher, MD and Edward V. Maytin, MD, PhD
    • Cleveland Clinic Journal of Medicine September 2026, 93 (9) 541-549;
    • DOI: https://doi.org/10.3949/ccjm.93a.26005
    • Early recognition and effective treatment are key to preventing these premalignant lesions from progressing to invasive squamous cell carcinoma.

  • MASLD and MASH: Steatotic liver disease joins the deadly quartet

    Risheng Xu, DO, Nicola Abate, MD, Rise Stribling, MD and Richard Su, PhD
    • Cleveland Clinic Journal of Medicine September 2026, 93 (9) 551-559;
    • DOI: https://doi.org/10.3949/ccjm.93a.25117
    • Like obesity, dyslipidemia, hypertension, and type 2 diabetes mellitus, metabolic dysfunction–associated steatotic liver disease is ubiquitous; however, awareness of it remains low.

  • Navigating pulmonary nodules: Guidelines on assessing risk and determining next steps in primary care

    CME Image
    Noah Gordon, DO, Raisa Munshi, MD, Mae Leef, DO, Axel W. Joob, MD and Abdul Hamid Alraiyes, MD
    • Cleveland Clinic Journal of Medicine August 2026, 93 (8) 475-484;
    • DOI: https://doi.org/10.3949/ccjm.93a.26004
    • The authors offer practical guidance on identifying pulmonary nodules that require surveillance, determining appropriate follow-up intervals, and deciding when specialist evaluation and intervention are needed.

  • Kratom at a crossroads: Trends, controversies, and the evidence gap

    Vania Modesto-Lowe, MD, MPH, Deanna Sgambato, DMS, MHS, PA-C, Jasleen Kaur, MD and Margaret Chaplin, MD
    • Cleveland Clinic Journal of Medicine August 2026, 93 (8) 487-492;
    • DOI: https://doi.org/10.3949/ccjm.93a.25088
    • Amid the opioid crisis, kratom use has grown for self-management of pain, mood symptoms, and opioid withdrawal.

  • TOC Icon

    Treatment-refractory hypothyroidism: Don’t just increase the dose

    CME Image
    Nabil William G. Sweis, MD and Jennifer S. Mammen, MD, PhD
    • Cleveland Clinic Journal of Medicine July 2026, 93 (7) 418-431;
    • DOI: https://doi.org/10.3949/ccjm.93a.25100
    • A systematic diagnostic approach can avert the cascade of unnecessary dose escalations and laboratory testing and the morbidity of persistent hypothyroidism.

  • TOC Icon

    Managing chronic kidney disease according to KDIGO risk categories: A primer for primary care

    Rodolfo J. Galindo, MD, Diana Soliman, MD, Joshua J. Neumiller, PharmD, Jay H. Shubrook, DO and Katherine R. Tuttle, MD
    • Cleveland Clinic Journal of Medicine June 2026, 93 (6) 353-365;
    • DOI: https://doi.org/10.3949/ccjm.93a.25072
    • The authors review the KDIGO guideline updates and provide a simplified treatment algorithm for non-nephrologists, focusing on medication sequencing and monitoring.

  • Reversing fibrosis in metabolic dysfunction–associated steatohepatitis—beyond telling patients to lose weight

    CME Image
    Leandro Sierra, MD, Lily Liu, MD, Akash Khurana, MD, Roma Patel, MD, Arjun Chatterjee, MD, Stephen Firkins, MD and Roberto Simons-Linares, MD
    • Cleveland Clinic Journal of Medicine May 2026, 93 (5) 279-286;
    • DOI: https://doi.org/10.3949/ccjm.93a.25082
    • Weight loss of at least 10% is associated with fibrosis regression in most patients, but losing this amount of weight and keeping it off is challenging, making pharmacologic and procedural interventions essential tools in clinical practice.

  • TOC Icon

    Clonal hematopoiesis of indeterminate potential and heart disease: What every internist needs to know

    Ohad Oren, MD, MPH, Abhay Singh, MD, Hetty E. Carraway, MD, MBA, Luke J. Laffin, MD and Steven E. Nissen, MD
    • Cleveland Clinic Journal of Medicine May 2026, 93 (5) 289-295;
    • DOI: https://doi.org/10.3949/ccjm.93a.26003
    • Clonal hematopoiesis is increasingly recognized as a driver of different types of heart disease, including ischemic heart disease, heart failure, arrhythmias, and nonischemic cardiac inflammation.

  • Sex-specific risk factors for stroke in women: Focus on the 2024 AHA/ASA guideline

    Paru S. David, MD, MSCP, Hannah Nordhues, MD, MSCP and Suneela Vegunta, MD, MSCP
    • Cleveland Clinic Journal of Medicine May 2026, 93 (5) 297-303;
    • DOI: https://doi.org/10.3949/ccjm.93a.25049
    • Sex-specific factors like adverse pregnancy outcomes and premature and early menopause play a critical and often underrecognized role in shaping lifetime stroke risk in women.

Previous